Stock Market Reviews

RDNT (RadNet, Inc.) News

Get the latest news, insights, and market updates on RDNT (RadNet, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• RadNet (RDNT): Valuation in Focus After Strong Earnings Beat and Raised 2025 Guidance
  RadNet (RDNT) shares climbed after the company reported stronger-than-expected quarterly results. Revenue and EBITDA grew due to higher imaging volumes, prompting management to raise guidance for 2025 and highlight ongoing investments in innovation. See our latest analysis for RadNet. RadNet’s momentum has been building, with recent quarterly beats and AI-fueled innovation helping the stock notch a 10.9% share price gain over the past month and a solid 7.97% total shareholder return over the...
  Nov 9, 2025 - $RDNT
• RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA¹ and Revises Upwards 2025 Financial Guidance Ranges
  Total Company Revenue increased 13.4% to $522.9 million in the third quarter of 2025 from $461.1 million in the third quarter of 2024; Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 51.6% to $24.8 million in the third quarter of 2025 from $16.4 million in the third quarter of 2024Total Company Adjusted EBITDA(1) was $84.9 million in the third quarter of 2025 as compared with $73.7 million in the third quarter of 2024, an increase of 15.2%; Digita
  Nov 9, 2025 - $RDNT
• RadNet Earnings: What To Look For From RDNT
  Diagnostic imaging company RadNet (NASDAQ:RDNT) will be announcing earnings results next tomorrow afternoon. Here’s what to expect.
  Nov 8, 2025 - $RDNT
• The Pennant Group, Inc. (PNTG) Tops Q3 Earnings and Revenue Estimates
  The Pennant Group (PNTG) delivered earnings and revenue surprises of +3.45% and +2.71%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 6, 2025 - $RDNT
• LifeStance Health Group (LFST) Reports Break-Even Earnings for Q3
  LifeStance Health (LFST) delivered earnings and revenue surprises of +100.00% and +2.30%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 6, 2025 - $RDNT
• Exploring Analyst Estimates for RadNet (RDNT) Q3 Earnings, Beyond Revenue and EPS
  Besides Wall Street's top-and-bottom-line estimates for RadNet (RDNT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
  Nov 6, 2025 - $RDNT
• RadNet Expands Comprehensive Remote Scanning Offering with Acquisition of Alpha RT’s Assets
  RadNet subsidiary DeepHealth to commercialize a robust end-to-end remote-imaging offering featuring both TechLive™ remote scanning technology and Alpha RT’s MRI staffing services and training programsLOS ANGELES, Nov. 05, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a US leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, today announced it has acquired the assets of Alpha RT, a pioneer in remote MRI scanning solutions an
  Nov 5, 2025 - $RDNT
• RadNet Announces the Agenda for its November 11, 2025 Investor Day
  LOS ANGELES, Nov. 04, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services and a premier global developer of digital health solutions, is pleased to unveil the agenda for the company’s Investor Day. The event will take place on Tuesday, November 11, 2025 from 9:00 a.m. to 2:30 p.m. Eastern Standard Time at the Nasdaq MarketSite in New York City. In-person attendance is by invitation only and investors can re
  Nov 4, 2025 - $RDNT
• RadNet (RDNT) Surged Following the Quarterly Results
  Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund rose 5.39% (Institutional Shares) in the quarter, compared to a 5.05% gain for the Russell 3000 Health Care Index (benchmark) and an 8.18% gain for the Russell 3000 […]
  Nov 4, 2025 - $RDNT
• Why The Narrative Around RadNet Is Shifting After Analyst Upgrades and Growth Signals
  RadNet stock has recently seen its consensus analyst price target rise from $74 to $81, signaling increased optimism about the company's future. This adjustment reflects growing confidence in RadNet's ability to capture sustained demand and capitalize on new growth opportunities. Stay tuned to discover how you can monitor these evolving forecasts and stay ahead of changes in RadNet's investment narrative. Stay updated as the Fair Value for RadNet shifts by adding it to your watchlist or...
  Nov 1, 2025 - $RDNT